Clopimozide [USAN:INN]

Suppliers

Names

[ CAS No. ]:
53179-12-7

[ Name ]:
Clopimozide [USAN:INN]

[Synonym ]:
5-Chlor-1-(1-4,4-bis(p-fluorphenyl)-butyl)-4-piperidyl)-2-benzimidazolinon
Clopimozida [INN-Spanish]
R 29,764
5-chloro-1{1-[4,4-bis(p-fluorophenyl)butyl]-4-piperidyl}-2-benzimidazolinone
Clopimozide [USAN:INN]
1-{1-[4,4-bis-(4-fluoro-phenyl)-butyl]-piperidin-4-yl}-5-chloro-1,3-dihydro-benzoimidazol-2-one
Clopimozide
Clopimozidum [INN-Latin]

Chemical & Physical Properties

[ Density]:
1.275g/cm3

[ Molecular Formula ]:
C28H28ClF2N3O

[ Molecular Weight ]:
495.99100

[ Exact Mass ]:
495.18900

[ PSA ]:
41.03000

[ LogP ]:
6.44830

[ Index of Refraction ]:
1.601

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DE2275800
CHEMICAL NAME :
2H-Benzimidazol-2-one, 1,3-dihydro-1-(1-(4,4-bis(4-fluorophenyl)butyl)-4-pip eridinyl)- 5-chloro-
CAS REGISTRY NUMBER :
53179-12-7
BEILSTEIN REFERENCE NO. :
0904611
LAST UPDATED :
199612
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C28-H28-Cl-F2-N3-O
MOLECULAR WEIGHT :
496.04

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
320 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - ptosis Behavioral - somnolence (general depressed activity) Behavioral - rigidity (including catalepsy)
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 25,1287,1975
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
170 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - ptosis Behavioral - somnolence (general depressed activity)
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 25,1287,1975
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
40 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - tremor Behavioral - convulsions or effect on seizure threshold
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 25,1287,1975
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
125 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - ptosis Behavioral - somnolence (general depressed activity) Behavioral - tremor
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 25,1287,1975

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

  • 1-butyl-4-fluoro-benzene
  • 5-Chloro-1-(4-Piperidyl)-2-Benzimidazolinone

DownStream

Related Compounds

  • (5R)-N-[(2S,3S)-2-(fluoromethyl)-2-hydroxy-5-oxooxolan-3-yl]-3-isoquinolin-8-yl-5-propan-2-yl-4H-1,2-oxazole-5-carboxamide
  • Rovelizumab [usan:inn]
  • Laronidase
  • Dasolampanel [USAN:INN]
  • Lorzafone [USAN:INN]
  • Nerelimomab
  • Benzoicacid,4-[1-(aminomethyl)ethenyl]-,methylester
  • 7-Benzyl-4-(3,5-difluorobenzyl)-1,2,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(4H)-one
  • 4-(4-Chlorobenzyl)-7-(4-ethynylbenzyl)-1,2,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(4H)-one
  • 5-({1-[4-Hydroxy-2-({[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl}carbamoyl)pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl}carbamoyl)pentanoic acid
  • 6-Bromo-5-methylpyridazine-3-carboxylic acid
  • Ethyl 3-((2,5-dimethylphenyl)amino)-3-(3-(isopentyloxy)phenyl)propanoate
  • 1-(3-Chloroprop-1-en-2-yl)-2-methanesulfonylbenzene
  • 2(1H)-Isoquinolinepropanoic acid, 3,4-dihydro-|A-hydroxy-, methyl ester
  • 1-Benzyl-4-((2-chloropyridin-3-yl)sulfonyl)piperazine
  • 7-Benzyl-4-(isoxazolidin-3-ylmethyl)-1,2,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(4H)-one
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.